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Abstract
Background: Using antibodies to specific protein antigens is the method of choice to assign and
identify cell lineage through simultaneous analysis of surface molecules and intracellular markers.
Embryonic stem cell research can be benefited from using antibodies specific to transcriptional
factors/markers that contribute to the "stemness" phenotype or critical for cell lineage.
Results:  In this report, we have developed and validated antibodies (either monoclonal or
polyclonal) specific to human embryonic stem cell antigens and early differentiation transcriptional
factors/markers that are critical for cell differentiation into definite lineage.
Conclusion:  These antibodies enable stem cell biologists to conveniently identify stem cell
characteristics and to quantitatively assess differentiation.
Background
Although the stem cell concept was introduced decades
ago, to date, stem cells can only be defined functionally,
not morphologically or phenotypically. Two functions
define stem cells. Firstly, they are self-renewing, thus able
to propagate to generate additional stem cells. Secondly
they can differentiate into various progenitor cells, which
commit to further maturation along a specific lineage.
While stem cells can be best defined functionally, a good
number of molecular markers have been used to prospec-
tively identify various stem cell populations. Although the
functional importance of many of these antigens remains
unknown, their unique expression pattern and timing of
expression provide a useful tool for scientists to identify as
well as isolate stem cells.
Embryonic stem cells (ESC), derived from the inner cell
mass of pre-implantation embryos, have been recognized
as the earliest stem cell population [1,2]. This pluripotent
population can differentiate into all somatic tissue includ-
ing germ cells. In the case of human ESC, they can differ-
entiate into some extra-embryonic derivatives as well. Like
mouse ESC, human ES cells can be maintained and prop-
agated on mouse fibroblast feeders for extended periods
in media containing basic fibroblast growth factor (bFGF)
[3]. Gene expression of undifferentiated human ES cells
has been investigated among several ES cell lines by a vari-
ety of techniques. They include comparison with data-
bases, reverse transcriptase-polymerase chain reaction,
focused cDNA microarrays, and immunocytochemistry. A
list of molecules comprised of known ES-specific or -
highly expressed genes and candidates that can serve as
markers for human ESCs and may also contribute to the
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"stemness" phenotype has been established [3-11]. For
example, pluripotent ESC can be characterized by high
level expression of Oct3/4 (POU domain, class 5, tran-
scription factor 1, Pou5f1) and Nanog, which are a mem-
ber of POU domain and homeobox transcription factors
respectively. A critical amount of Oct3/4 and Nanog
expression is required to sustain stem-cell pluripotency
and both of these markers are downregulated as cells dif-
ferentiate in vitro and in vivo [4-9]. Antibodies to Oct3/4
which cross react with human Oct 3/4 have been widely
used to monitor the presence of undifferentiated ESC.
No single marker however is sufficient or unique for iden-
tifying ESCs. Oct3/4 for example is expressed by germ cells
and may be expressed by specific populations later in
development. Likewise, Nanog has been shown to express
in other tissues. We and other have noted however, that
while no single marker is sufficient a constellation of pos-
itive and negative markers can in concert unambiguously
allow one to define the state of ESC cultures and that sur-
face markers in combination can be used to prospectively
sort for ESC.
Based on published data at the level of gene expression,
we have cloned a number of candidate marker genes. We
have also expressed the recombinant protein and gener-
ated a panel of monoclonal or polyclonal antibodies to
these proteins. Using these antibodies we have confirmed
the specificity and selectivity of these antibodies on sev-
eral ESC lines and established their utility as stem cells
markers. Our results confirm the expression pattern and
timing of these cell markers at the protein level, whereas
previous data reported at the level of gene expression.
Results and discussion
Characterization of undifferentiated human ES cells and 
differentiated EBs by antibodies
All monoclonal antibodies were initially selected for their
abilities to recognize recombinant proteins in direct ELI-
SAs. A subset were also tested by Western Blot analysis
using recombinant proteins and cell lysate to confirm
binding to a single epitope. The best clone was later
screened for its applications for immunocytochemistry
and flow cytometry using various cell lines. Human
peripheral blood platelets were used for screening mouse
anti-human CD9 antibody. MCF-7 cells were used for
screening mouse anti-human E-Cadherin and PODXL
(podocalyxin-like) antibodies. MG-63 cells were used for
screening mouse anti-human GATA1 (GATA binding pro-
tein 1) antibody. Beta-TC6 cells were used for screening
for mouse anti-human/mouse PDX-1 (pancreatic duode-
nal homeobox-1) antibody. NTERA-2 cells were used for
screening mouse anti-human Oct3/4 and SOX2 (sex-
determining region Y-box 2) antibodies. All polyclonal
antibodies were affinity-purified using recombinant pro-
teins and validated by direct ELISAs and Western. Caco-2
cells were used for validation of goat anti-human GATA6
antibody and NTERA-2 cells were used for validation of
goat anti-human Nanog and anti-human Oct3/4 antibod-
ies (Summarized in Table 1).
After antibodies were validated in direct ELISAs, Western
blot or cell lines (Fig. 1 and data not shown), they were
used to examine the expression of individual molecules in
undifferentiated human ES cells and differentiated EBs.
When examined by immunohistochemistry, high level of
expressions of Oct3/4, SOX2, E-Cadherin, PODXL and
Nanog were observed in undifferentiated human ES cells
(Fig. 2A, 2B and 2C). DPPA5 (developmental pluripo-
tency associated 5) expression was also observed in undif-
ferentiated human ES cells (data not shown). We noted
that a subset of the proteins used were membrane bound
proteins. To test if any of the antibodies generated could
recognize an extracellular epitope and thus be used for
live cell sorting, we repeated staining of live cells as previ-
ously described. The CD9, E-Cadherin and PODXL anti-
bodies recognized an extracellular epitope and their
ability to select cells by FACS was confirmed (Fig. 3). Min-
imal or no expressions of Oct3/4, E-Cadherin, PODXL
and Nanog were detected in the differentiated EBs (Fig.
2D, 2E and 2F). However, SOX2 expression, which is
observed in neural progenitor cells, is persistent in subsets
of EBs.
Suspension culture with FGF withdrawal is known to
induce differentiation of ES cells to all three germ layer
precursors [12]. The differentiation status of the EB used
here was detected to contain all germ cell markers by RT-
PCR (Fig. 4). In order to examine how more antibodies
Table 1: Summary list of antibody verification by western blot.
Antibody Sample used for analysis Mol. Wt. (KD)
Gt × hBrachyury mouse ES-derived EB lysate 48
Ms × hDPPA5 N/A N/A
Gt × hGATA6 Caco2 cell lysate 65
Gt × hNanog NTERA-2 cell lysate 33
Gt × hOct 3/4 NTERA-2 cell lysate 39
Gt × hPDX1 beta-TC 6 cell lysate 32
Gt × hSOX17 mouse ES-derived EB lysate 45
Ms × hCD9 PBMC 25
Rt × hGATA-1 N/A N/A
Ms × hE-Cadherin MCF-7 cell lysate 97
Ms × hPODXL MCF-7 cell lysate 57
Ms × hSOX2 NTERA-2 cell lysate 36
N/A: 1. DPPA5 is still being subcloned. Only Elisa verification is 
available.
2. The clone for GATA-1 (MAB1779) does not work for Western 
blot application but is useful for IHC, The clone picked for Western 
blot analysis does not work for IHC (MAB17791, see data in http://
www.rndsystems.com).BMC Developmental Biology 2005, 5:26 http://www.biomedcentral.com/1471-213X/5/26
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can be used for characterization of early differentiation
events from human ES cells, we examined the expressions
of endodermal markers, SOX17, GATA6 and PDX-1, and
mesodermal markers, Brachyury and GATA1, in the undif-
ferentiated human ES cells and differentiated EBs. Expres-
sions of SOX17, GATA6, PDX-1, Brachyury and GATA1
were not detected in undifferentiated human ES cells
(data not shown). In contrast to the undifferentiated ES
cells, subpopulations of SOX17-, GATA6-, Brachyury- and
GATA1-positive cells were observed (Fig 4). These results
suggest that both endodermal and mesodermal precursors
exist in EBs with FGF withdrawal for 8 days. However, no
PDX-1-positive cells were seen in EBs differentiated with
the same treatment (data not shown).
Examination of cross-reactivity of antibodies on mouse ES 
and differentiated cells
We have also examined the cross-reactivities of these anti-
bodies to mouse ES cells using mouse D3 ES cell line and
mouse fetal endodermal tissue. Cross-reactivity to mouse
of goat anti-Oct3/4, goat anti-PDX-1, goat anti-SOX17
and mouse anti-SOX2 was detected. Minimal cross-reac-
tivity to mouse, measured by 10% intensity to human by
higher than control cells, was observed in mouse anti-
CD9 and mouse anti-E-cadherin antibodies. Goat anti-
Nanog and mouse anti-PODXL antibodies appear to be
human-specific as well (data not shown). The subtypes of
monoclonal antibodies were also identified in the best
clones. These results are summarized in Table 2.
Table 2: Summary of antibodies detection in ES and EB samples.
Antibody ES EB Reactivity to mouse Isotype of monoclonal antibody 
(Clone No.)
Gt × hBrachyury No Yes NT*
Ms × hDPPA5 Yes NT* NT* ND*
Gt × hGATA6 No Yes NT*
Gt × hNanog Yes Down No
Gt × hOct 3/4 Yes Down Yes
Gt × hPDX-1 No No Yes
Gt × hSOX17 No Yes Yes
Ms × hCD9 Yes No Minimal Mouse IgG2B (clone 209306)
Ms × hE-cadherin Yes No Minimal Mouse IgG2B (clone 180224)
Ms × hGATA1 No Yes NT* Rat IgG2B (clone 234732)
Ms × hPODXL Yes No No Mouse IgG2A (clone 222328)
Ms × hSOX2 Yes Yes Yes Mouse IgG2A (clone 245610)
*NT, Not tested; ND, Not determined.
Western blot analysis for Gt × hOct3/4 (A), Gt × hNanog (B) and Ms × hSOX2 (C) in NTERA-2 cell lysate, Ms × hE-Cadherin  (D) in MCF-7 cell lysate, Ms × hCD9 (E) in PBMC lysate and Ms × hPDX-1(F) in β-TC-6 cell lysate Figure 1
Western blot analysis for Gt × hOct3/4 (A), Gt × hNanog (B) and Ms × hSOX2 (C) in NTERA-2 cell lysate, Ms × hE-Cadherin 
(D) in MCF-7 cell lysate, Ms × hCD9 (E) in PBMC lysate and Ms × hPDX-1(F) in β-TC-6 cell lysate. Numbers indicate the posi-
tions of molecular weight markers.BMC Developmental Biology 2005, 5:26 http://www.biomedcentral.com/1471-213X/5/26
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Undifferentiated human ES cells (A, B, and C) and differentiated EBs (D, E and F) were analyzed using antibodies to indicated  molecular markers Figure 2
Undifferentiated human ES cells (A, B, and C) and differentiated EBs (D, E and F) were analyzed using antibodies to indicated 
molecular markers. Immunostaining with goat anti-human Oct3/4 (Red in A and D), mouse anti-human SOX2 (Green in A and 
D), goat anti-human E-Cadherin (Red in B and E), mouse anti-human PODXL (Green in B and E), and goat anti-human Nanog 
(Red in C and F), are contrasted with DAPI nuclear staining (Blue in C-F). Note the dramatic downregulation of ESC specific 
markers (Oct3/4, E-Cadherin, PODXL, and Nanog) in EBs. However, SOX2 expression is persistent in subsets of EB cells. 
Scale bars = 100 µm.BMC Developmental Biology 2005, 5:26 http://www.biomedcentral.com/1471-213X/5/26
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Conclusion
The expression patterns detected using antibodies devel-
oped in our facility are consistent with data reported using
reverse transcriptase-polymerase chain reaction or cDNA
microarrays. Moreover several of the monoclonal anti-
bodies have differing heavy chain subunits allowing dou-
ble labeling using subtype specific markers to be
performed.
In summary, we have developed a useful collection of
antibodies that would be useful for identification of stem
cell characteristics and assessment of differentiation. Sev-
eral additional antibodies to the molecules that have been
identified as potential cell lineage markers [13] are cur-
rently under development using the same approach.
Methods
Cloning and expression of Brachyury, DPPA5, CD9, E-
Cadherin, GATA1, GATA6, Nanog, Oct3/4, PDX-1, 
PODXL, SOX2 and SOX17
Brachyury (aa. 1–202), DPPA5 (a.a. 1–116), GATA1 (a.a.
1–413), GATA6 (aa. 1–449), Nanog (aa. 153–305), Oct3/
4 (aa. 1–265), PDX-1 (aa. 1–283), SOX2 (aa. 135–317)
and SOX17 (aa. 177–414) were expressed in E. Coli and
extracellular domains of CD9, E-Cadherin, PODXL were
expressed in mouse NSO cells. All proteins were purified
and sequenced before they were used as antigens for
immunizations and as substrate for antibody screening
and subcloning.
Production and purification of antibodies
All monoclonal antibodies were derived from fusions of
mouse myeloma with B cells obtained from BALB/c mice
which had been immunized with purified antigen. The
IgG fraction of the culture supernatant was purified by
Protein G affinity chromatography (Sigma). Each panel of
antibodies was screened and selected for their abilities to
detect purified recombinant antigen in direct ELISA and
Western blot. All polyclonal antibodies were derived from
sera of goats which had been immunized and boost it
with purified antigen. Antibody was purified from the sera
by an antigen-affinity chromatography.
Cells and cell culture
Human Caco-2, MG-63, MCF-7, NTERA-2 and mouse D3
cells were purchased from American Type Culture Collec-
tion (ATCC). Cells were cultured according to the ATCC
instructions. Information regarding human ES cell line
HSF-6 (NIH code UC06) can be obtained at the website
[14]. Undifferentiated human ES cells were cultured
according to the protocol provided by the University of
California, San Francisco in human ES culture medium
[DMEM supplemented with 20% KnockOut Serum
Replacement (Invitrogen) and 5 ng/mL of bFGF (R&D
Systems)]. To induce formation of embryoid bodies
Human embryonic stem cells stained with anti-CD9 (A), anti- E-Cadherin (B), and anti-PODXL (C) and antigen expression  detected by a flow cytometer Figure 3
Human embryonic stem cells stained with anti-CD9 (A), anti-
E-Cadherin (B), and anti-PODXL (C) and antigen expression 
detected by a flow cytometer. The specific staining is indi-
cated by green histogram and corresponding isotype control 
is indicated by black histogram.BMC Developmental Biology 2005, 5:26 http://www.biomedcentral.com/1471-213X/5/26
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(EBs), ES colonies were harvested, separated from the
MEF feeder cells by gravity, gently resuspended in ES cul-
ture medium and transferred to non-adherent suspension
culture dishes (Corning). Unless otherwise noted, EBs
derived from human ES cell aggregates were cultured for 8
days in ES culture medium deprived of bFGF and used for
analysis by immunohistochemistry as described.
Western blot
Cells are solubilized in hot 2× SDS gel sample buffer (20
mM dithiothreitol, 6% SDS, 0.25 M Tris, pH 6.8, 10%
glycerol, 10 mM NaF and bromophenyl blue) at 2 × 106
per mL. The extracts are heated in a boiling water bath for
5 minutes and sonicated with a probe sonicator with 3–4
bursts of 5–10 seconds each. Samples are diluted with 1×
SDS sample buffer to the desired loading of 1–5 × 103 per
lane. Lysates were resolved by SDS-PAGE, transferred to
Immobilon-P membrane, and immunoblotted with 0.5
µg/mL primary Abs as described in R&D Systems Website
[15].
Immunohistochemistry
Antibodies were used with the appropriate secondary rea-
gents at a concentration of 5 to 10 µg/ml. Cells or sections
of EBs were fixed with 4% paraformaldehyde in PBS at
room temperature for 20 min, then blocked and permea-
bilized with 0.1% Triton X-100, 1% BSA, 10% normal
donkey serum in PBS at room temperature for 45 min.
After blocking, cells were incubated with diluted primary
antibody overnight at 4°C followed by coupled anti-
mouse or anti-goat IgG (Molecular Probes) at room tem-
perature in the dark for an hour. Between each step cells
were washed with PBS with 0.1% BSA.
RT-PCR
Total RNA was extracted from EBs using Trizol LS (Invit-
rogen). cDNA was synthesized by using Superscript II
Differentiated EBs were analyzed by either immunocytochemistry or RT-PCR to the indicated molecular markers Figure 4
Differentiated EBs were analyzed by either immunocytochemistry or RT-PCR to the indicated molecular markers. (A) Immu-
nostaining with goat anti-human SOX17 (Red), is contrasted with Fluoro Nissl nuclear staining (Green). (B) Immunostaining 
with goat anti-human GATA6 (Red), is contrasted with DAPI nuclear staining (Blue). (C) Immunostaining with goat anti-human 
brachyury (Red), is contrasted with DAPI nuclear staining (Blue). (D) Immunostaining with mouse anti-human GATA1 (Red). 
Note that each antibody recognizes subsets of EB cells. Scale bars = 100 µm. (E) The differentiation status of EB is detected by 
RT-PCR using different germ layer cell markers. Selected endoderm markers AFP, FoxA2; mesoderm markers Hand1, MSX1 
and ectoderm marker Msl1 were all highly expressed in the EB samples while their expression was either undetectable or at 
low level in the ES samples. G3PDH was a positive control showing similar amount of RNA samples were used for analysis.Publish with BioMed Central    and   every 
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reverse transcriptase (Invitrogen) according to the manu-
facturer's recommendations. The PCR primers are availa-
ble upon request.
Flow cytometry
Antibodies were prepared at the concentration of 0.1 mg/
mL. 10 µL of the stock solution was added to 1 – 2.5 × 105
cells in a total reaction volume not exceeding 200 µL. The
sample was then incubated for 20 min at 2–8 °C. Follow-
ing incubation, excess antibody was removed by washing
cells twice with FACS buffer (2% FCS and 0.1% sodium
azide in Hank's buffer). After wash, cells were resuspend
in 200 µL of FACS buffer and the binding of unlabeled
monoclonal antibodies was visualized by adding 10 µL of
a 25 µg/mL stock solution of a secondary developing rea-
gent such as goat anti-mouse IgG conjugated to a fluoro-
chrome for 20 min at 2–8°C. Following incubation, cells
were washed once with FACS buffer, once with PBS. After
wash, cells were resuspend in 400 µL of PBS and analyzed
on a FACScant flow cytometer (Becton-Dickinson, Moun-
tain View, CA). Five thousand events were collected and
analyzed using CELL Quest software.
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